Literature DB >> 19898774

Musculoskeletal manifestations in patients with malignant disease.

Tamer A Gheita1, Yasser Ezzat, Safaa Sayed, Ghada El-Mardenly, Waleed Hammam.   

Abstract

To detect and describe the incidence of musculoskeletal manifestations in different malignant diseases as well as their relation to the treatment received whether by chemotherapy or radiation therapy. Sixty patients with different malignant diseases were included in this study, 45 with solid tumors and 15 patients with hematological malignancy. The mean age was 46.55 +/- 11.04 years and the mean disease duration was 2 +/- 0.75 years. The patients were fully examined for any rheumatologic involvement, laboratory investigations were performed as well as dual energy X-ray absorptiometry study for bone densitometry. Treatment strategies were assessed including the chemotherapeutics, radiation therapy, and/or surgery. Myalgias and arthralgias were the most frequent followed by flexor tenosynovitis, frozen shoulder, and fibromyalgia syndrome. Hypertrophic osteoarthropathy was seen in five patients, cutaneous vasculitis in two patients as well as arthritis. Osteonecrosis was present in one of the lunate carpal bones of a patient with non-Hodgkin's lymphoma (1.67%) and receiving high dose steroids. Rheumatoid factor was positive in four patients, three of which had hepatitis C virus positivity and cryoglobulins. Anti-neutrophil cytoplasmic antibody was negative in all the studied patients. The bone mineral density was significantly reduced in the patients with malignancy compared to the control. Mild to moderate osteoporosis was present, being more evident in the spine and forearm. The bone loss was higher in those with solid tumors and even more obvious in those receiving aromatase inhibitors. Musculoskeletal manifestations occurring during malignancies and following the treatment represent a significant percentage of symptoms and signs which may raise a clue to differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19898774     DOI: 10.1007/s10067-009-1310-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  58 in total

Review 1.  Rheumatologic features of hematologic disorders.

Authors:  M Ehrenfeld; H Gur; Y Shoenfeld
Journal:  Curr Opin Rheumatol       Date:  1999-01       Impact factor: 5.006

2.  Kienböck's disease in a patient with Crohn's enteritis treated with corticosteroids.

Authors:  R W Culp; J L Schaffer; A L Osterman; F W Bora
Journal:  J Hand Surg Am       Date:  1989-03       Impact factor: 2.230

3.  Chemotherapy-related arthropathy.

Authors:  Mi-Jeong Kim; Young-Min Ye; Hae-Sim Park; Chang-Hee Suh
Journal:  J Rheumatol       Date:  2006-07       Impact factor: 4.666

4.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Authors:  A Howell; J Cuzick; M Baum; A Buzdar; M Dowsett; J F Forbes; G Hoctin-Boes; J Houghton; G Y Locker; J S Tobias
Journal:  Lancet       Date:  2005 Jan 1-7       Impact factor: 79.321

5.  Risk factors for joint symptoms in patients enrolled in the ATAC trial: a retrospective, exploratory analysis.

Authors:  Ivana Sestak; Jack Cuzick; Francisco Sapunar; Richard Eastell; John F Forbes; Angelo R Bianco; Aman U Buzdar
Journal:  Lancet Oncol       Date:  2008-08-12       Impact factor: 41.316

6.  Cutaneous vasculitis as an initiating paraneoplastic symptom in Hodgkin lymphoma.

Authors:  Zsófia Simon; Tünde Tarr; László Tóth; Gabriella Szucs; Arpád Illés
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

7.  Postchemotherapy rheumatism.

Authors:  C L Loprinzi; J Duffy; J N Ingle
Journal:  J Clin Oncol       Date:  1993-04       Impact factor: 44.544

Review 8.  Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation.

Authors:  D Saadoun; D A Landau; L H Calabrese; P P Cacoub
Journal:  Rheumatology (Oxford)       Date:  2007-06-12       Impact factor: 7.580

Review 9.  Aromatase inhibitors and musculoskeletal pain in patients with breast cancer.

Authors:  Loren Winters; Karleen Habin; Joan Gallagher
Journal:  Clin J Oncol Nurs       Date:  2007-06       Impact factor: 1.027

10.  Cutaneous vasculitis in breast cancer treated with chemotherapy.

Authors:  Maida Wong; Jennifer Grossman; Bevra H Hahn; Antonio La Cava
Journal:  Clin Immunol       Date:  2008-07-21       Impact factor: 3.969

View more
  7 in total

Review 1.  Rheumatology in Egypt: back to the future.

Authors:  Tamer A Gheita; Nahla N Eesa
Journal:  Rheumatol Int       Date:  2018-11-07       Impact factor: 2.631

Review 2.  [Hypertrophic osteoarthropathy. Bamberger-Marie disease].

Authors:  B Manger; A Lindner; K Manger; J Wacker; G Schett
Journal:  Z Rheumatol       Date:  2011-09       Impact factor: 1.372

Review 3.  An overview of effective and potential new conservative interventions in patients with frozen shoulder.

Authors:  Michel Gcam Mertens; Mira Meeus; Olivier Verborgt; Eric H M Vermeulen; Ruud Schuitemaker; Karin M C Hekman; Donald H van der Burg; Filip Struyf
Journal:  Rheumatol Int       Date:  2021-09-06       Impact factor: 2.631

Review 4.  Risk Factors for Shoulder Stiffness: Current Concepts.

Authors:  Davide Cucchi; Antongiulio Marmotti; Silvana De Giorgi; Alberto Costa; Rocco D'Apolito; Marco Conca; Alessandro Russo; Maristella F Saccomanno; Laura de Girolamo
Journal:  Joints       Date:  2017-12-11

5.  Frozen shoulder and risk of cancer: a population-based cohort study.

Authors:  Alma B Pedersen; Erzsébet Horváth-Puhó; Vera Ehrenstein; Mikael Rørth; Henrik T Sørensen
Journal:  Br J Cancer       Date:  2017-05-18       Impact factor: 7.640

6.  Rehabilitation of Advanced Cancer Patients in Palliative Care Unit.

Authors:  Chang Hyun Lee; Jong Kyu Kim; Hyun Jung Jun; Duk-Joo Lee; Wook Namkoong; Jae Ho Oh
Journal:  Ann Rehabil Med       Date:  2018-02-28

7.  The Prevalence of Systemic Rheumatic Diseases Among Breast Cancer Patients and Its Relationship With Survival.

Authors:  Veli Sunar; Öztürk Ateş; Alma Korcali Aslan; Yusuf Karakaş; Mustafa Kadri Altundağ
Journal:  Arch Rheumatol       Date:  2018-08-16       Impact factor: 1.472

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.